young tumor infiltrating lymphocytes
Cell therapyexperimental
Clinical trial activity
8 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
7
Phase 3
0
Phase 4
0
Earliest trial started Jul 7, 2010 (NCT01174121)
Timeline
Indications
Studied for
- Adenocarcinoma · Phase 2
- Anus Neoplasms · Phase 2
- Breast Neoplasms · Phase 2
- Carcinoma, Adenosquamous · Phase 2
- Carcinoma, Non-Small-Cell Lung · Phase 2
- Carcinoma, Squamous Cell · Phase 2
- Colorectal Neoplasms · Phase 2
- Melanoma · Phase 2
- Neoplasms · Phase 1
- Neuroendocrine Tumors · Phase 2
- Oropharyngeal Neoplasms · Phase 2
- Ovarian Neoplasms · Phase 2
- Pancreatic Neoplasms · Phase 2
- Penile Neoplasms · Phase 2
- Skin Neoplasms · Phase 2
- Uterine Cervical Neoplasms · Phase 2
- Vaginal Neoplasms · Phase 2
Mechanism of action
- Tumor antigensImmunity, passive
Tumor antigens immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- young tumor infiltrating lymphocytes
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02621021 | Phase 2 | Nov 25, 2015 | National Cancer Institute (NCI) |
| NCT02133196 | Phase 2 | Apr 17, 2014 | National Cancer Institute (NCI) |
| NCT01993719 | Phase 2 | Nov 19, 2013 | National Cancer Institute (NCI) |
| NCT01814046 | Phase 2 | Mar 1, 2013 | National Cancer Institute (NCI) |
| NCT01585428 | Phase 2 | Apr 13, 2012 | National Cancer Institute (NCI), National Institutes of Health (NIH) |
| NCT01585415 | Phase 1 | Apr 9, 2012 | National Cancer Institute (NCI) |
| NCT01319565 | Phase 2 | Mar 9, 2011 | National Cancer Institute (NCI) |
| NCT01174121 | Phase 2 | Jul 7, 2010 | National Cancer Institute (NCI) |
Showing 8 of 8 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Cancer Institute (NCI) | Government | 8 | 8 | 2 | 2010 |
| National Institutes of Health (NIH) | Government | 1 | 0 | 1 | 2012 |
2 organizations
Page 1 / 1